AVVH Stock Overview
AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
AVVAA World Health Care Products, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0016 |
| 52 Week High | US$0.0036 |
| 52 Week Low | US$0.00075 |
| Beta | 0 |
| 1 Month Change | 15.11% |
| 3 Month Change | 14.29% |
| 1 Year Change | -40.74% |
| 3 Year Change | -90.00% |
| 5 Year Change | 1,500.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| AVVH | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 14.3% | -4.2% | -3.7% |
| 1Y | -40.7% | -2.0% | 20.5% |
Return vs Industry: AVVH underperformed the US Biotechs industry which returned -1.7% over the past year.
Return vs Market: AVVH underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| AVVH volatility | |
|---|---|
| AVVH Average Weekly Movement | 32.2% |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AVVH's share price has been volatile over the past 3 months.
Volatility Over Time: AVVH's weekly volatility (32%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Jason Price | avvaaworldhealth.com |
AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne.
AVVAA World Health Care Products, Inc. Fundamentals Summary
| AVVH fundamental statistics | |
|---|---|
| Market cap | US$2.12m |
| Earnings (TTM) | US$17.18m |
| Revenue (TTM) | US$37.46k |
0.0x
P/E Ratio0.0x
P/S RatioIs AVVH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVVH income statement (TTM) | |
|---|---|
| Revenue | US$37.46k |
| Cost of Revenue | US$10.20k |
| Gross Profit | US$27.26k |
| Other Expenses | -US$17.16m |
| Earnings | US$17.18m |
Last Reported Earnings
Aug 31, 2010
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did AVVH perform over the long term?
See historical performance and comparison